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MDMA (‘Ecstasy’) on the Developing Fetus
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Abstract
MDMA (3, 4-methylenedioxymethamphetamine) is an illicit, recreational drug known by many individuals as ‘Ecstasy.’
MDMA has gained popularity over the past decade and has become a drug of choice at dance parties and clubs because
of the stimulating and hallucinogenic effects that it has on the central nervous system. Scientists have determined that
MDMA causes neurotoxic damage to adults by harming the serotonergic system in the adult brain. Researchers discovered that embryos exposed to MDMA while in utero also suffer neurotoxic deficits, although not due to impairments in
the embryos’ serotonergic systems. These deficits arise because of the cortisol increase that is found in adults after ingestion of MDMA, which can be transmitted to a developing fetus and thereby lead to a reprogramming of the hypothalamic-pituitary-adrenal axis in the fetus. In addition, MDMA can ca use changes in the norepinephrine and/or dopamine
systems in a developing fetus and thus create lasting neurological damage. MDMA-induced elevation of Atg5, a protein
involved in autophagy, leads to teratogenesis in a developing fetus by inhibiting neuronal growth and differentiation. In
another vein, 3, 4-Dihydroxymethamphetamine (HHMA) and malondialdehyde (MDA), two main metabolites of MDMA,
have toxic effects on an embryo and are another mechanism via which Ecstasy can cause impairments in the fetal brain.
While these and other hypotheses are currently under much investigation, scientists are approaching this topic with the
understanding that it is most probably an interplay of many biological changes that result from fetal exposure to MDMA
that together create the neurological defects observed in these fetuses. The various aspects of MDMA and the damage
it can have on a fetus have been researched by the author using the Touro database and various links to journals and
articles that this database provided.
Introduction
MDMA, known scientifically as 3, 4-methylenedioxymethamphetamine, is an amphetamine derivative drug increasing in
popularity amongst teenagers and young adults (Broening, et al.,
2001). Amphetamines are a class of molecules that have stimulating effects on the central nervous system (CNS). MDMA is
known by recreational users as ‘Ecstasy’ because it has stimulating and hallucinogenic effects on the CNS while engendering immediate feelings of ecstasy and openness upon ingestion
(Singer, et al., 2012).
Studies show that adults taking MDMA have a decrease in serotonin (5-HT) in the brain, a reduction in 5-hydroxyindoleacetic
acid (5-HIAA), a main metabolite of serotonin, and a reduction
in tryptophan hydroxylase (TPH), an enzyme involved in the
synthesis of serotonin (Broening, et al., 2001). This serotonergic
reduction is harmful to the exposed adult. Interestingly, though
the effects of MDMA on adults have been well researched, few
studies have been conducted on the effects of MDMA on prenatally exposed children and on the reasons for these effects.
Due to its popularity amongst teenagers and young adults, it
has become increasingly prevalent to find developing fetuses
exposed to MDMA while in utero. Scientists are determining
the long term neurological effects of Ecstasy-exposed fetuses by
conducting post parturition studies on both rats and children
that have been prenatally exposed to MDMA. Some long term
neurotoxic effects include sequential and spatial learning delays
(Broening, et al., 2001) milestone delays at 4 months of age, and
poorer mental development index scorings at 12 months of age
(Singer, et al., 2012). The question stands as to why these and

other neurotoxic effects develop in both rats and children that
have been exposed to MDMA in utero. Scientists are hypothesizing numerous reasons for these effects, including serotonin
(5-HT) reduction (Broening, et al., 2001), elevated levels of cortisol (Parrott, et al., 2014), changes in the norepinephrine (NE)
system (Thompson, et al., 2011) and in the dopamine (DA) system (Thompson, et al., 2009), an increase in autophagy protein
5 (Atg5) (Chae, et al., 2009), and embryotoxicity due to MDMA
metabolites (Barenys, et al., 2012). This paper explores various
venues theorized to be the cause of the cognitive and neuronal
impairment observed in Ecstasy-exposed fetuses.

Methods
Research on the topic of the biological reasons for the neurotoxic effects of MDMA on the developing fetus was compiled
from various sources found in the Touro database. Information
was obtained regarding general usage of MDMA as well as
the observations noted in children of women who ingested
MDMA while pregnant. Finally, data about various experiments
performed on rats was obtained in order to gain insight into
possible biological causes for the neurotoxic deficits noted in
MDMA exposed fetuses. The information was arranged into a
comprehensive order and edited by the author.

Discussion
One strong hypothesis as to how Ecstasy induces long term
brain damage in a fetus is that MDMA-exposed fetuses are
harmed due to a decrease in 5-HT in the brain. This hypothesis
is based on the established fact that MDMA causes serotonergic
reductions in the adult brain. In a study done on Sprague-Dawley
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rats, researchers in the University Of Cincinnati College Of
Medicine sought to determine whether the effects of MDMA
on exposed fetuses are indeed caused by a 5-HT reduction.
Sprague Dawley rats were mated and their litters were reduced
to 8 pups, 4 males and 4 females, with parturition day termed P0.
The rats were divided into 2 groups. One group received two
subcutaneous injections of MDMA daily on P1-P10 while the
second group received similar MDMA injections on P11-P20.
These intervals of P1-P10 and P11-P20 correspond to early and
late third trimester development in humans, respectively.
Between P60 and P80, the rats were tested in various assigns.
The results of the tests illustrated that the rats in the P11-P20
group had significant decreases in sequential learning, spatial
learning, and memory abilities, while those in the P1-P10 group
did not show significant decreases in any of these areas. Neither
group showed a significant decrease in cued learning. These
tests demonstrate that the neurotoxic effects that MDMA has
on a developing fetus are more likely to occur when MDMA is
taken during late third trimester development and that these
effects are long term, as seen from the presence of the impairments in rats that had already reached adulthood.
The researchers sought to determine whether these cognitive
impairments in the rats were due to serotonergic decreases
in the rat brains. In order to investigate this hypothesis, the
rats were decapitated on P105 and their brains were dissected.
Reductions in 5-HT in the hippocampus were found for both
the P1-P10 and P11-P20 groups, findings that do not correlate
with the cognitive impairments seen only in the P11-P20 groups.
In addition, the frontal cortex of the rats displayed 5-HT reductions only in the P11-P20 group, but these reductions were insignificant as seen with a correlation coefficient between these
reductions and the spatial learning deficits exhibited by the rats
that did not approach significance. Therefore, while this study
shows that MDMA has long term negative effects on spatial
and sequential learning and memory, it also illustrates that these
cognitive deficits are not due to serotonergic reductions. The
cause of fetal brain damage by MDMA must be via a mechanism
other than the 5-HT reduction that causes MDMA induced
damage in the adult brain (Broening, et al., 2001).
This idea that prenatal MDMA exposure and the long term
damage that it causes is not due to 5-HT reduction can be supported by the mechanism via which MDMA causes 5-HT reduction in the adult brain. Studies indicate that MDMA metabolites
form free radicals upon further metabolism and thereby damage serotonergic neurons. This is supported by the presence
of malondialdehyde in rat brains after exposure to MDMA.
Malondialdehyde is an end product of lipid peroxidation, the
process during which lipids in cell membranes are broken down
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via free radicals. Because free radicals are hard to measure due
to their short half-lives, the by-products of these radicals known
as TBARS (thiobarbituric acid reacting substances) are used to
measure the damage induced by the free radicals. The TBARS
Assay is a test that reacts thiobarbituric acid with malondialdehyde in order to quantify the amount of free radicals found
in a specimen. This reaction yields a florescent product that
indicates the presence of free radicals. Thus, a high yield of
malondialdehyde from a TBARS Assay found in adult rats exposed to MDMA indicates the presence of free radicals in these
rats. Another indication of the presence of free radicals in rats
exposed to MDMA is that 5-HT reduction is prevented from
occurring in MDMA-exposed rats that are injected with alphaphenyl-N-tert-butyl nitrone (PBN), a free radical scavenger. This
indicates that the 5-HT reduction occurring in adult rats may
be happening in part because of free radicals. A study exposing
both neonate and adult rats to MDMA showed no significant
increase in the presence of malondialdehyde in the hippocampus and cortex of the neonate rats while the adults’ brain cortices did demonstrate a significant increase in malondialdehyde
(Figure 1). Free radicals cause the serotonergic reduction in
adult rats, and it can be inferred that cognitive defects found
in adult humans exposed to MDMA are caused by this 5-HT

Figure 1

Figure 1 - Formation of thiobarbituric acid reacting substances
(TBARS) in the hippocampus and cortex of adult rats and cortex of
neonate rats 3 h (hatched columns) and 6 h (cross-hatched columns)
after MDMA (40 mg kg71, i.p.) administration. Results show %
change in brain malondialdehyde (MDA) formation compared to
saline-injected control animals (open columns), as mean+s.e.mean,
n=8± 10. *Significantly different from saline (Colado, et al., 1997).
reduction. In contrast, neonatal rats and, by inference, humans
prenatally exposed to MDMA, have cognitive impairments that
cannot be attributed to 5-HT reductions (Colado, et al., 1997).
Other factors must be explored to lend reason for these long
term neurotoxic effects.
Another possible cause for the cognitive deficits recognized
in children prenatally exposed to MDMA is elevated levels of
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cortisol caused by ingestion of Ecstasy. As noted, MDMA has
been shown to cause impairments in long term memory, learning, and locomotor activity in children exposed to this drug in
utero. Researchers hypothesize that these impairments may be
due to the increase in cortisol that is present. Individuals ingesting Ecstasy display higher levels of cortisol in comparison
to drug-free individuals with baseline cortisol levels. In addition,
increased cortisol levels may be damaging to fetal development.
Therefore, if the Ecstasy user is a pregnant woman, her MDMA
usage may put her fetus at risk (Parrott, et al., 2014).
Cortisol is a glucocorticoid steroid hormone produced by the
adrenal cortex in response to bodily stress and/or low blood
glucose levels. The body releases this hormone in order to provide additional metabolic resources that enable an individual to
function properly while under stress. The hypothalamic- pituitary-adrenal (HPA) axis is a systemic interaction of endocrine
glands that utilize a negative feedback mechanism in order to
control the hormonal activities of the adrenal cortices (Mosby’s
Medical Dictionary, 2009).
In a recent study performed on MDMA users, light usage of
MDMA (ingestion of MDMA 1-4 times within the past 3
months) led to a mean increase of 50% in cortisol levels, in contrast with a control group of MDMA-free individuals. Heavier
Ecstasy users (ingestion of MDMA 5+ times within the past 3
months) were noted to have a mean increase of 400% in their
cortisol levels in comparison with a control group. While these
statistics definitely illustrate radical increases in cortisol levels
in MDMA users, a 10% increase of maternal cortisol leads to a
mere 1% increase in fetal cortisol. This is due to the placental
glucocorticoid barrier that prevents most of the cortisol from
reaching the fetus. However, while a small increase in maternal
cortisol levels may not cause damage to a fetus, a 400% increase
in maternal cortisol can possibly have long term deleterious effects on the child.
According to the scientific review by Parrott, et al.(2014), “…
HPA basal hyperactivation…may represent a complex neuroendocrine dysfunction associated with MDMA use.” They imply
that elevated cortisol levels caused by MDMA ingestion may
lead to HPA axis impairments, specifically in a developing fetus.
This idea is supported by a study on the effects of maternal
stress on a fetus, because researchers have found that similar
to ingestion of MDMA, an increase in a mother’s stress level
causes more cortisol to be produced, and this hormone is then
passed to the fetus via the placenta. As noted, although most
of the cortisol is prevented from reaching the fetus due to the
placental glucocorticoid barrier, about 1/10th of the cortisol
will still reach the fetus. This hormone may then reprogram the
HPA axis activity of the developing fetus which can cause long

term damaging effects on the child. Studies illustrate that the
negative effects of stress on the developing fetus include poorer
attention spans, sleeping, feeding, and activity problems, greater impulsivity, and a higher pervasiveness of Attention Deficit
Hyperactivity Disorder (ADHD). Because ingestion of MDMA
causes an increase in cortisol in the same way that maternal
stress does and because cortisol has been shown to cross the
placental barrier, researchers infer that it is the elevated cortisol
levels found in MDMA users that are responsible for the neurotoxic deficits found in Ecstasy-exposed fetuses and that the
long term effects of MDMA may mirror the effects of maternal
stress on a fetus.
It is interesting to note that increased cortisol levels can be seen
in an individual for up to 3 months after he/she has stopped
using MDMA. Thus, it follows that a woman who stops MDMA
usage prior to pregnancy may still be liable to inflict lasting
damage to her fetus unless she has had several months of drug
abstinence prior to conception (Parrott, et al., 2014).
A study researching the connection between elevated cortisol
levels and memory problems supports the idea that elevated
cortisol levels may be the cause of long term damage in MDMAexposed fetuses, specifically in the area of memory impairment.
Researchers tested healthy individuals with a mean age of 61.8
years to determine if memory problems are linked to elevated
cortisol levels. This study used a special testing method in order
to control for any stress that would develop in the subjects
because of the inherent knowledge of their memory loss. The
study demonstrated that women with memory complaints
had significantly higher levels of cortisol than women without
memory complaints, although no such difference was seen in
men. In addition, individuals who complained of memory issues
also had increased activity of their HPA axes (Wolf, et al., 2004).
Similar to the adults in this study, fetuses exposed to MDMA
also had elevated cortisol levels and hyperactivity of their HPA
axes (Parrott, et al., 2014). In a similar vein, a study performed
on cocaine dependent individuals served to analyze the cause
for the learning and memory dysfunctions observed in these
drug addicts. Researchers determined that cocaine dependent
individuals have higher levels of cortisol than individuals in a
‘cocaine-free’ control group, and this increase was associated
with the poorer learning and memory skills observed in these
individuals (Fox, et al., 2009).Thus, it can be inferred that the
memory impairments noted in children prenatally exposed to
MDMA may be caused by the elevated cortisol levels that these
fetuses are exposed to.
Another hormone that may be linked to the damage induced
by MDMA in the developing fetus is norepinephrine (NE). NE
is a noradrenergic hormone and neurotransmitter made from
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dopamine (DA) by the enzyme dopamine beta hydroxylase
(DBH). It is released from the adrenal medulla into the bloodstream and acts as a systemic hormone, and it is also released
from noradrenergic neurons in the locus ceruleus of the brain
where it acts as a neurotransmitter. Scientists have found that
a correlation exists between prenatal exposure to MDMA in
rats and changes in the structure and function of the NE system in these prenatally exposed rats. NE system dysfunction
has been associated with exaggerated behavioral responses to
new stimuli as well as a decrease in habituation to these stimuli, impairments which are attributed to attentional processing
deficits. Because researchers have observed these behaviors in
prenatally exposed rats, they infer that the damage induced by
MDMA exposure to a developing fetus may be linked to abnormal wiring of the fetus’s NE system (Thompson, et al., 2011).
In order to test this hypothesis, pregnant Sprague-Dawley rats
were randomly assigned to two groups. One group was injected
with 15mg/kg of MDMA twice a day at 8 hour intervals, a dose
consistent with the typical MDMA dosage taken for human
consumption, while the other group received subcutaneous
injections of saline two times a day at corresponding 8 hour
intervals. These injections were administered from embryonic
day 14 (E14) to embryonic day 21 (E21).The pups were born on
E21 and the first day after parturition was termed postnatal day
1 (P1).The litters were reduced to 4 males and 4 females for the
MDMA group and 5 males and 5 females for the saline group.
The pups were anesthetized on P21 and their brains were removed and cut into specific sections for observational analysis.
Among the different areas of the brain that were analyzed, three
sections of the rostral hippocampus, CA1, CA2, and CA3, were
scrutinized for NE abnormalities. This section of the brain was
studied because it is receives noradrenergic innervation from
the locus ceruleus and because it is involved in spatial memory
and responses to novelty, abilities that have been found lacking in MDMA exposed fetuses. The rats prenatally exposed to
MDMA exhibited a 32.1% increase in DBH fiber density in the
CA1 region of the hippocampus in comparison with the control
group. In addition, norepinephrine transporter (NET), a molecule that regulates NE signaling by clearing NE from the synaptic
cleft, increased in MDMA rats by 39.3% in the CA1 region and
32.1% in the CA3 region. In spite of these increases, the rostral
hippocampus displayed no elevation in NE levels and levels of
3-methoxy-4-hydroxyphenolglycol (MHPG), a main metabolite
of NE. The locus ceruleus displayed no increase in DBH fibers,
and NET binding did not increase in this area. However, in the
prelimbic (Cg3) region of the prefrontal cortex, there was a
69.2% increase in DBH neurites. This was accompanied by a
15% increase in NE in the prefrontal cortex as a whole, although
there was no increase in NET binding or MHPG levels in the
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prefrontal cortex.
These findings suggest that MDMA can cause NE system dysfunction in the developing fetus. As an example, the increase
in NET binding observed in the CA1 and CA3 regions of the
hippocampus illustrate that MDMA caused more NE to continue to be present in these areas even after exposure, or that
the high levels of NE found in the hippocampus during MDMA
exposure led to a sustained increase in NET binding in these
areas as a form of systemic regulation. Because NE in the CA1
region of the hippocampus plays a big role in communication
signaling between the hippocampus and entorhinal cortex, NE
abnormalities in this region may lead to communication deficits
which in turn may lead to impairments in spatial learning and
working memory. In fact, as illustrated in other studies previously mentioned, these deficits have been found in rats exposed to MDMA while in utero. Also, as mentioned previously,
NE increases have been related to exaggerated responses to
novelty and attentional processing impairments. These deficits
also correlate with a study that observed that rats exposed to
MDMA while in utero had increased levels of responsivity to a
new cage at P21, an increase that persisted into adulthood as
far as P61-P62. Therefore, it can be theorized that NE system
changes caused by rat embryonic exposure to MDMA, and, by
inference, NE system changes caused by human fetal exposure
to MDMA, lead to many of the impairments observed in children prenatally exposed to MDMA. Changes in the noradrenergic system that develop in the fetus as a result of MDMA exposure have direct links to the deficits noted in these children
post-parturition.
It is worth mentioning that the results of the MDMA exposure
are noted on P21, and that this corresponds to the early teenage years in humans.Thus, NE system changes and the resulting
impairments can be effective in this time period. These systemic deficits may be the cause of the impulsivity and ‘search for
novelty’ that is present amongst many young adults that often
leads to substance abuse or reckless behavior (Thompson, et
al., 2011). Perhaps the mothers ingesting MDMA while pregnant are unknowingly setting the stage for substance abuse in
their children many years down the line.
In a similar study, scientists determined that fetal rat exposure
to MDMA affects the fetus’s dopamine (DA) system. These effects can be seen by a five-fold increase in dopamine neuron
fibers in the prefrontal cortex of the rat brain as well as by
smaller increases in DA fiber density in the striatum and nucleus accumbens of rats exposed to MDMA while in utero.
DA has many pathways in the brain, one of which is the mesocortical tract, a pathway that transports DA from the ventral
tegmentum to the frontal cortex. The pathway is known to
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influence exploratory behaviors, impulsivity, and a search for
novelty. When this system is impaired, the results can cause hyperactivity and are sometimes linked to behavioral issues such
as ADHD. Because changes in the DA system of both humans
and rats is associated with decreased habituation to novelty
and increased locomotor activity, this study sought to discover
whether the changes in the DA system noted in the rats exposed to MDMA could be correlated with significant changes
in these particular behavioral areas (Thompson, et al., 2010).
The study tested Sprague Dawley rats that were injected with
MDMA on embryonic day 14-20, as well as a group of ‘control’
rats, and measured their behavior on postnatal day 21. Many

packaging unneeded cytoplasm and organelles into vesicles
known as autophagosomes in preparation for degradation
so that the cell can recycle these particles. After an isolation
membrane elongates and surrounds unneeded cellular particles, an autophagosome is formed which fuses with a lysosome,
eventually leading to the catalytic breakdown of the extraneous
cellular particles. Seven proteins known as autophagy-related
proteins regulate this process. These proteins are grouped into
two distinct categories – the Atg12 system (comprised of Atg
5, 7, 10, and 12) which involves regulating the elongation of
the autophagosome isolation membrane, and the Atg8 system
(comprised of Atg 3,4,7, and 8), a system involved in regulating
the attachment of the phospholipids in the autophagosome

Figure 2

This diagram illustrates images of fetal brain development of various rat embryos that received specific doses of MDMA on gestational
day 8.5. Note how the teratogenic effects pointed out by the arrows are in concordance with the higher dosages of MDMA (Chae, et
al.,2009)
behavioral areas such as home cage locomotor activity, running
wheel activity, gravitation towards a high fat diet, and cocaine
self-administration levels where tested. However, the only areas
of behavior that had significant results in comparison with the
control group were the rats’ decreased acclimation to new
environments, increased perseverance to find a cued platform,
and increased locomotion in the center of an open field which
served as an indication of the rats’ decreased levels of anxiety. Thus, the researchers hypothesized that the rats exposed
to MDMA in utero had alterations in their dopamine systems,
specifically in the mesocortical pathway. They conjectured that
a possible cause for the decreased habituation to novelty and
increased perseverance seen in the rats was caused by impairments that the MDMA wreaked on the fetal rats’ developing
DA systems (Thompson, et al., 2010).
Another study researching deficits found in fetuses exposed
to MDMA explores impairments in neuronal differentiation
that arise due to an increase in an autophagy-related protein
5 (Atg5). Autophagy is an intracellular process that involves

membrane (Chae, et al., 2009).
Defects in the autophagy system have been linked to various
physiological impairments. In this study, researchers discovered
that rats embryos injected with MDMA had elevated levels of
Atg5.The study explanted rat embryos after 8.5 days of gestation
and administered dos es of 2.5, 5, and 10 micrograms of MDMA
to the embryos.When the embryonic mRNA was sampled, it was
noted that Atg5 expression had doubled after 48 hours of MDMA
exposure and that extreme teratogenesis and fetal brain damage
was observed in the rats (Figure 2). In order to determine if this
brain damage occurred due to impairment of neuronal differentiation, human neuroblastoma SH-SY5Y cells were divided into
two groups, a control group and a group injected with 10 micrograms of MDMA. The group of cells administered with MDMA
illustrated an increase of 1.8 times the amount of Atg5 mRNA
expression after 48 hours. Furthermore, when a sample of SHSY5Y cells was induced with a green florescent protein vector
(GFP), a protein used as a marker of genetic expression, in the
presence of a plasmid encoding for Atg5, the cells did not express
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Figure 3

This figure depicts the SH-SY5Y cells that were induced with GFP
vector and retinoic acid for 5 days.The control group (top row) was
imaged after 5 days while the test group (bottom row) was induced
with Atg5 and also imaged after 5 days. Neurite extension and
arborization is present and can be seen in the control group while no
extension and arborization is present in the test group (Chae, et al.,
2009).
any neurite extensions or arborizations (fine branching at the
end of the neurite fiber). This was in the presence of retinoic
acid, a metabolite of vitamin A that usually aids in growth and
development. In contrast, a control group of SH-SY5Y cells induced with a GFP vector and retinoic acid in the absence of Atg5
exhibited extensive neurite extension and arborization (Figure
3). This demonstrates that an increase in Atg5 impairs neuronal
growth and differentiation.Therefore, because an increase in Atg5
is found to impair the differentiation of SH-SY5Y neuroblastoma
cells, it can be inferred that the teratogenesis observed in rats exposed to MDMA that is accompanied by an increase in Atg5 can
be attributed to a similar mechanism of impairment of neuronal
differentiation (Chae, et al,. 2009).
An additional area that can be explored in order to explain the
neuronal impairments discovered in fetuses exposed to MDMA
is the metabolites that MDMA forms upon ingestion. As stated previously, when MDMA enters the body, it is broken down
into substances that are further metabolized into free radicals.
This is supported by the presence of malondialdehyde (MDA)
in rat brains after exposure to MDMA, because MDA is one of
the end products of lipid peroxidation, a process during which
lipids in cell membranes are broken down via free radicals.
However, MDMA forms other metabolites aside from MDA,
depending on which enzymes are present to break it down.
Therefore, while the formation of the MDA metabolite accounts for the breakdown of 20-90% of MDMA ingested by rats,
3, 4-Dihydroxymethamphetamine (HHMA) is a metabolite of
MDMA that is formed upon human consumption and accounts
for 53-81% of MDMA metabolism in humans. The difference in
MDMA metabolism that results in the formation of MDA or
HHMA is very slight. Ortho-demethylenation of MDMA, which
occurs in humans, leads to the formation of HHMA, while
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Figure 4

Figure 4 - This diagram illustrates the two main metabolic
pathways of MDMA. O-demethylenation produces HHMA and is
the main pathway that occurs in humans while N-demethylation
produces MDA and is the main metabolic pathway that occurs in
rats (Barenys, et al., 2012).
N-demethylation, occurring in rats, leads to the formation of
MDA (Figure 4). MDMA does metabolize into MDA in humans,
as does MDMA metabolize into HHMA in rats, but only trace
amounts of these metabolites are found in humans and rats,
respectively (Barenys, et al., 2012).
Researchers have found that the presence of HHMA or MDA
while a fetus is developing can lead to embryonic defects in the
fetus. Scientists explanted embryos from Sprague Dawley rats
after 9.5 days of gestation and injected various embryos with
MDMA, MDA, and HHMA. The concentrations of the injections
for each substance were 5, 15, 25, and 50 micrograms. They
discovered that the embryos injected with 25 and 50 micrograms of MDMA had a decrease in crown-rump length (CRL), a
measurement of the fetus from the top of the head (crown) to
the bottom of the buttocks (rump). In addition, abnormal tissue
formations, known as dysmorphogeneses, were observed in the
rats injected with 50 micrograms of MDMA. These dysmorphogeneses displayed themselves as an opening in the superior
frontal tissue of the head, termed an open cranial neural pore,
an abnormal prominence in the inferior frontal part of the head,
termed a protuberant nasal placode, and a disproportionately
small forebrain in comparison with the midbrain and hindbrain
(Barenys, et al., 2012).
Similarly, the embryos injected with doses of MDA displayed a
decrease in their CRL after receiving a dose of 50 micrograms
of MDA. These rats also exhibited dysmorphogeneses such as
the posterior part of the embryonic trunk located behind the
embryo instead of in front of it, termed an abnormal flexion,
an abnormal caudal part of the embryo that was marked by a
bend in the distal part of the embryo’s trunk, abnormally shaped
somites, and unusual narrowing of the otic vesicles that represented the formation of irregular ears (Barenys, et al., 2012).
The embryos injected with doses of HHMA also displayed
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similar anomalies. Interestingly, the group of embryos injected
with 50 micrograms of HHMA died upon exposure to this
concentration of metabolite. Therefore, the doses were modified to 10, 20, 30, and 40 micrograms of HHMA per group of
embryos. At both 30 and 40 micrograms of HHMA, the CRL of
the embryos significantly decreased. Additionally, dysmorphogeneses such as abnormal flexion, a protuberant nasal placode,
and an abnormal yolk sac (an anomaly marked by a yolk sac that
was not properly rounded or was missing vasculature) were
noted in the embryos injected with 40 micrograms of HHMA
(Barenys, et al., 2012).
This research indicates that MDMA severely damages a developing fetus due to the toxic metabolites that are formed
upon MDMA ingestion. However, it must be addressed why the
dysmorphogeneses noted in the fetuses exposed to MDMA
differed from those noted in the fetuses exposed to MDA
and HHMA. While some of the abnormalities such as a protuberant nasal placode and decreased CRL were seen in both
the MDMA-exposed embryos and the MDA and/or HHMAexposed embryos, there were anomalies noted in the MDA and
HHMA-exposed embryos that were not found in the MDMAexposed embryos. This presents a problem, because MDA and
HHMA are metabolites of MDMA and therefore, all of the
anomalies found in an embryo exposed to these metabolites
should be found in an embryo exposed to MDMA. Perhaps this
can be explained by the fact that MDMA forms many metabolites upon ingestion, aside from MDA and HHMA. It is possible
that the ‘other’ metabolites of MDMA interact with one another and ‘change’ the irregularities noted in embryos exposed to
MDA or HHMA to represent those seen in embryos exposed
to MDMA.
Additionally, it is worth focusing on the fact that the HHMA
killed the embryos that received injections of 50 micrograms
while this did not occur to the embryos receiving injections
of 50 micrograms of MDA. HHMA is the main metabolite of
MDMA in humans, and this finding suggests that it is more toxic
than MDA, the main metabolite of MDMA that is found in rats.
Because many of the studies available today about MDMA and
its harmful effects have used rats as their method of research,
perhaps humans need to be extra cautious when ingesting
MDMA. This is because the negative effects that MDMA has
been shown to display in rats is probably greater in humans
since HHMA is the main metabolite of MDMA in humans and
appears to be a more toxic metabolite than MDA.

memory, decreased habituation to novelty, poorer mental development index scorings, and other neurological impairments.
While researchers have determined the negative effects that
MDMA has on a fetus, the biological reasons for these effects
are still being researched extensively. Scientists have determined
that these deficits are not due to 5-HT reductions in the brain.
However, these defects may be caused by changes in the fetuses’
cortisol levels, systemic NE or DA changes that are caused by
exposure to MDMA, an increase in Atg5 that leads to inhibition of neuronal growth and differentiation, or the embryotoxic
effects of HHMA and MDA, two main metabolites of MDMA.
These explanations require further research to determine how
they interrelate with one another. Additional studies can investigate the interactions of all of the systemic changes caused by
fetal exposure to MDMA to explore how these interactions
bring about the cognitive deficits noted in MDMA-exposed
fetuses. While this area of research has yet to be explored, individuals should take note that the harmful effects of MDMA have
already been determined with certainty and that consumption
of this drug should be avoided.
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